The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them if confirmed. We ...
The Centers for Medicare & Medicaid Services (CMS) finalized significant updates to the Medicare 60-Day Rule, which governs ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
An expanding prohibition on third-party financial guarantees could lead to more nursing home using lawsuits to collect unpaid ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.
CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...
The Centers for Medicare & Medicaid Services (CMS) recently announced two significant updates to Workers’ Compensation ...